Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Don't ever remember the word "imminent" in the PPHM vocabulary before but sure beats "soon!" Thanks James. Love your very confident work.
Be careful what you wish for. My quiet day has evaporated. Oh well.
What a civil board this has become! Quite, reasonable and intelligent. Hope it stays that way.
Very gratifying headline on iHub front page today:
“When our perils are past, shall our gratitude sleep?” ~ Michel de Montaigne Thank you to all the Veterans!
RS is a myth. Plain and simple. Promoted by those who want PPHM to fail. Too obvious.
CONSISTENT 8,000 READS EVERY DAY NOW!!!! EVERY DAY!!!! LOL!!!!!
And no RS coming. It's just a ploy. No RS.
LOL, 2300 reads already today!!!!
Okay TT, here is why we have 3200 SUNDAY reads already today - Tradero's anti-PS antibodies article from late October posted a few minutes ago:
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=126353314
Where else can you find such up-to-date info concerning PPHM's platform than right here, all in one package? Yes, reads do count for those of us who want Tustin to succeed.
I get the gist TT. I read your post and I thought I had read that post probably a thousands times in one variation or other over the last xmonths. It's almost as if we just word it correctly, all will agree and we can take our ball and go home. Anyway you slice it, if one is fair as you appear to be, it doesn't matter what we post, only what comes out of Tustin, CA. And right now that ain't much. I'm hope that that "ain't much" means partnership soon.
Okay, I'm okay with that. With so very little, if anything coming out of Tustin, this "biomarker" (reads) might mean something.
Up 4,100 reads in 90 minutes to 5,540!!!! And it's Sunday morning.
True, but bots search many other stock boards too, so you'd think would all show such increases in reads. I'm not trying to make federal case of this, just pointing out that the dog barked in the night. (Silver Blaze, Sherlock Holmes)
Okay, a zillion posts here try to make us believe that our 30 cent company is doomed, hopeless, the Titanic of biotechs. Looming RS, failed trails, clueless BOD, on and on. This many reads, day after day, indicate to me, however, that others outside our little world of 100 posts per day, are following our 30 cent company because they know PPHM has the goods and are waiting to invest OR are outside entities wanting to control the dialogue here.
I am not all-knowing. I just present a simple fact that day after day we have very high “reads.” Nothing to get your dander up – just an observation from a lowly poster.
BTW, 1375 reads already today (Sunday) on just 8 posts!!!
6,000 reads today so far. Lazy Saturday, football in the air and we get 6,000 reads. Some great things are coming.
Same old RS non-news. Nobody is buying it. BTW, you'll outlast me here if you're a member. Everyone knows the score here, so enjoy your weekend.
6 months extension, as you well know. PPHM headed for great things. RS argument is dead on arrival.
All this obvious attention against Peregrine Pharmaceuticals indicates good things are coming.
Nice Tek. I recall similar posts in the past, especially the fun "rocket years", and here you are again, as am I, waiting. I think the waiting will be over this year. Take care.
7th game: I made it till the rain delay and thought, oh no, wait another 2 hours after waiting 200 years. So turned off the TV! What news in the morning! Grew up in Chicago and know all the angst, now gone.
I think that's how it will all turn out with PPHM. We'll "wake-up" soon, I hope, to great news! This price action sure smells, what with Avid. Makes no sense, unless...
Okay Wernaaa, have a quiet weekend and watch some football. Got news for you...what comes, comes. 500,0000,000 posts, whatever. My Cubbies won, finally, and so will Tustin.
Your post encourages me! Thanks. In fact, each of your posts is an encouragement. Keep on posting!
LOL. Board reads getting negative attention which means they're right on!!! LOL!!!!
Great comparison EB, biomarkers to reads. Never thought of that.
It's so interesting that such a simple post mentioning reads brings on such attention!!!
Pretty cool dude if you are holding 200,000 shares.
The stock is 29 cents and has been failing gradually for weeks. What attracts 14,000 reads to such a trading pattern? Who would possibly be interested? I find it also very enlightening that every time I raise this issue, I get immediate blow-back. I'm in JamesGMS camp that says PPHM is going to take off....soon.
James, wonder why this board 14,000 reads EOD! 17th most read board. 29 cent stock holds an awful lot of interest.
jakedogman1
Wednesday, 11/02/16 02:54:56 PM
Re: None
Post # of 277808
it will be ugly until a deal is done... no support, no institutional interest, not enough retail...
and what would prompt a deal?
BP is on the search for combos... lag3, pd1, ps receptors like tim-3 etc and the race to stay in front or even get past the starting line (AZN)
pphm has to do some type of deal... they have no choice... do they let the avid window of opportunity pass them by? the IP value can disappear as well unless it's put into stronger hands... so the choice is with which BP imo... and twenty months profitable? Given their vague pr’s will it be one cent a share or one dollar bottom line? They are just giving shareholders bs…. They know they don’t have 20 months…
how many upstream checkpoint options are available?…. And for the big player w/ research dollars, the question is not just a particular drug, it’s the entire pathway…. Roche and Lilly have research programs for TIM-3 while others have many drug candidates…
SK appears with merck and agenus at partnering conference... merck lag3 pdl1, agenus lag3, preclinical pphm gaga over lg3 and pd1
and the likes of msk, duke, utsw indicate this is worth pursuing with preclinical with pd1, lag3, radiation combo, tnbc….
and with "personalized therapies" ie where does the drug benefit a patient and how is that determined with biomarkers etc, we have yet to see the results…
look at the abbvie $5.8 bil stemcentrx acquisition…. Note the comment… Rova-T is a novel biomarker-specific therapy that is derived from cancer stem cells and targets delta-like protein 3 (DLL3) that is expressed in more than 80 percent of SCLC patient tumors and is not present in healthy tissue.
So a drug that was targeted to the right patients actually performed?
and the NOL's which start to expire are worth something to a profitable BP.. (very complicated) my wag is anywhere from $100 mil plus? and companies are being bought out now just for the NOL's... so to a profitable BP with a 20% marginal tax rate, they can risk a decent investment basically risk free (the one asset that mgmt. did a wonderful job in creating value is the cumulative net operating loss that actually has value to a profitable company. There, I said something positive about mgmt.)
http://www.hancockaskew.com/net-operating-losses/
so we should have the ingredients for some type of deal...
what i find interesting is the attention being paid to a $.32 stock
260 mil shares traded since feb 26.... look at the volume over the last few months... retail can’t buy, institutions won’t touch… so someone has their finger on the scale…. Big short with all the potential? Don’t think so…
All the ingredients for a deal When will the dam break?
2600 reads already today for 32 cent stock. Not bad!!! Others outside this stock board are reading us!!!
Thanks Jake, again, for one of the most balanced posters here.
ALMOST 9,000 READS TODAY!!!!!
Amazing what attention a very simple post attracts! Like bees or their cousins to honey. Only OTC stock doing better post-wise and they need constant attention.
ALMOST 9,000 READS TODAY!!!!!
Excellent NMD! Nice to read common sense here backed up by FACTS. 75 cents for Avid! Remarkable claim but your expertise puts that figure in its proper place. Well done.
You know what you're missing. It's the only thing that makes sense holding down this sp for month and months.
JamesGMS Thursday, 09/29/16 01:46:36 PM
Re: bfiest post# 273816
Post #
273874
of 277393 Go
bfiest, re your post below:
Quote:
Now we're playing psychological games with the market using the reverse split as an investment tool to stimulate more growth. We need to come back to our senses. If PPHM has the goods the rewards will be there and hopefully before a reverse split is ever needed. Is this possibly over thinking the situation? Likely. Let's remove the possibility of a reverse split and focus on value. 240M OS is nothing if Bavi is what it appears to be. Do what is necessary to ensure its success but don't get cute with wall street. That is not good business. Just focus on creating value like every other successful business on wall street. Let's not let our imaginations run wild.
#1 They have the "goods" - as will be clearly demonstrated "Soon" : )
#2 There will of course be no reverse split - as the rapidly approaching "validation" of the IP - {aka "creating value"} will shortly remove any need for same.
#3 Imagination can be a good thing - unless it's driven by fear or outside manipulation. So I concur with bfiest - and would urge all to just relax and instead use your imagination to think about what you may do once the PPS finally begins its inexorable ascent.
Enjoy the day.
James
Good to remind some of us here what MH said less than a month ago:
masshysteria Thursday, 09/29/16 05:57:03 PM
Re: cjgaddy post# 273899
Post #
273908
of 277387 Go
Thanks for posting cj and much to be excited about in here.
As a reference point, likely known to many on this board. Dr. Wolchok is a direct and significant contributor for the development and commercialization of both Ipilimumab and Nivolumab. He and his lab were there with BMY early on from discovery, development and through market research and ultimately launch. He is one of the world's most renowned experts on Melanoma as a disease, and the mechanisms and pathways associated with it. To state the obvious - he is also still very closely tied with further development of the products and any potential combinations that may induce the next level of response beyond what PD1 and CTLA4 can achieve on their own.
He was involved in study 1 and is also a contributing author. His work is changing the course of disease in humanity and he will be credited with delivering tremendous benefits to Oncology and patients as more Melanoma patients get treated with Nivolumab and survive what otherwise would be a death sentence.
And he's working with Bavituximab.
He's also working with mice. He always had. Even when developing Ipi and Nivo.
Should give anyone who is objective about the current state of affairs in Peregrine a pause and an appreciation of what the possibilities are. These people are drawn to high-potential and work with the largest of the largest in industry. They feel it is worth their time to spend it on Bavi-inclusive combinations.
I'm taking that as a positive sign.
Thanks much for sharing and best,
MH
I don't see any retail selling because of postings here. The selling IMO will come when investors pull the trigger too soon after coming out of the deep ravine we've been in since forever. But long investors have got the number of outside entities here.
Big, big difference between cell phone technology and human cell technology. Like maybe a factor of several trillion combinations.
Old or new investor, who cares! We just want one, that partnership.
No delivery complications with bavi.